logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
Journal Article
|Short Report

Treatment outcomes of patients switching from an injectable drug to bedaquiline during short standardized MDR-TB treatment in Mozambique

Bastard M, Molfino L, Mutaquiha C, Galindo MA, Zindoga P, Vaz D, Mahinça I, DuCros P, Rusch B, Telnov A
Download

Similar Content
Loading...
Loading...
Loading...
Treatment outcomes of patients switching from an injectable drug to bedaquiline during short standardized MDR-TB treatment in Mozambique | Journal Article / Short Report | MSF Science Portal
Abstract
Bedaquiline was recommended by WHO as the preferred option in treatment of MDR-TB patients with long regimen. However, no recommendation was given for the short MDR-TB regimen. Data from our small cohort of patients who switched injectable dug to bedaquiline suggest that bedaquiline based short regimen is effective and safe.

Languages

English
DOI
10.1093/cid/ciz196
Published Date
11 Mar 2019
Journal
Clinical Infectious Diseases
Volume | Issue | Pages
Volume 69, Issue 10, Pages 1809-1811
Dimensions Badge